The DOI matches its Crossref record; 356 of the 356 references it cites were found in a registry or an index.
Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
Open accessAbstract
Although schizophrenia is an illness that has been historically characterized by the presence of positive symptomatology, decades of research highlight the importance of cognitive deficits in this disorder. This review proposes that the theoretical model of cognitive control, which is based on contemporary cognitive neuroscience, provides a unifying theory for the cognitive and neural abnormalities underlying higher cognitive dysfunction in schizophrenia. To support this model, we outline converging evidence from multiple modalities (eg, structural and functional neuroimaging, pharmacological data, and animal models) and samples (eg, clinical high risk, genetic high risk, first episode, and chronic subjects) to emphasize how dysfunction in cognitive control mechanisms supported by the prefrontal cortex contribute to the pathophysiology of higher cognitive deficits in schizophrenia. Our model provides a theoretical link between cellular abnormalities (eg, reductions in dentritic spines, interneuronal dysfunction), functional disturbances in local circuit function (eg, gamma abnormalities), altered inter-regional cortical connectivity, a range of higher cognitive deficits, and symptom presentation (eg, disorganization) in the disorder. Finally, we discuss recent advances in the neuropharmacology of cognition and how they can inform a targeted approach to the development of effective therapies for this disabling aspect of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
The attention system of the human brain
Posner, M. I., & Petersen, S. E. (1990) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.13.030190.000325 · Cited by 8,070 · cited 1×
“The activation of parietal regions provides the DLPFC with the ability to shift attentional focus and provides information on learned stimulus–response pairings (Bunge et al, 2002, 2003; Miller and Cohen, 2001; Posner and Petersen, 1990).”
BackgroundConflict monitoring and cognitive control
Botvinick, M. M., Braver, T. S., Barch, D. M., Carter, C. S., & Cohen, J. D. (2001) · Psychological Review · doi:10.1037/0033-295x.108.3.624 · Cited by 7,351
Self-citationNeurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
From Neuropsychology to Mental Structure
Shallice, T. (1988) · doi:10.1017/cbo9780511526817 · Cited by 4,072
Holroyd, C. B., & Coles, M. G. H. (2002) · Psychological Review · doi:10.1037/0033-295x.109.4.679 · Cited by 4,027
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
MacDonald, A. W., Cohen, J. D., Stenger, V. A., & Carter, C. S. (2000) · Science · doi:10.1126/science.288.5472.1835 · Cited by 3,666
Self-citation
Cited by
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Prefrontal–hippocampal interactions in episodic memory
Eichenbaum, H. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.74 · Cited by 870
Marek, S., & Dosenbach, N. U. F. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.2/smarek · Cited by 836
Cognition in schizophrenia: core psychological and neural mechanisms
Barch, D. M., & Ceaser, A. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.015 · Cited by 747
Dendritic spine pathology in schizophrenia
Glausier, J. R., & Lewis, D. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.044 · Cited by 581
Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia
Gonzalez-Burgos, G., Cho, R. Y., & Lewis, D. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.010 · Cited by 497
Gonzalez-Burgos, G., & Lewis, D. A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs010 · Cited by 478
Glutamate hypothesis in schizophrenia
Uno, Y., & Coyle, J. T. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12823 · Cited by 367
Millan, M. J., Fone, K., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 347
Emotion deficits in people with schizophrenia
Kring, A. M., & Elis, O. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185538 · Cited by 318
Curley, A. A., Arion, D., Volk, D. W., Asafu-Adjei, J. K., Sampson, A. R., Fish, K. N., & Lewis, D. A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010052 · Cited by 283
Chase, H. W., Boudewyn, M. A., Carter, C. S., & Phillips, M. L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0499-9 · Cited by 286
Self-citationThe NMDA Receptor and Schizophrenia
Balu, D. T. (2016) · Advances in Pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 285
Executive Functioning in Schizophrenia
Orellana, G., & Slachevsky, A. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00035 · Cited by 277
Fornito, A., Yoon, J., Zalesky, A., Bullmore, E. T., & Carter, C. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.019 · Cited by 277
Self-citationMemory and cognition in schizophrenia
Guo, J. Y., Ragland, J. D., & Carter, C. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0231-1 · Cited by 258
Self-citationDynamics of cognitive control: Theoretical bases, paradigms, and a view for the future
Gratton, G., Cooper, P., Fabiani, M., Carter, C. S., & Karayanidis, F. (2018) · Psychophysiology · doi:10.1111/psyp.13016 · Cited by 255
Self-citationDendritic spines: Revisiting the physiological role
Chidambaram, S. B., Rathipriya, A. G., Bolla, S. R., Bhat, A., Ray, B., Mahalakshmi, A. M., Manivasagam, T., Thenmozhi, A. J., Essa, M. M., Guillemin, G. J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.005 · Cited by 255
Delevich, K., Tucciarone, J., Huang, Z. J., & Li, B. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4565-14.2015 · Cited by 226
“…1994; Mitelman et al., 2005; Zhou et al., 2007; Schlösser et al., 2008; Minzenberg et al., 2009) and deficits in prefrontal cortical PV INs (Lisman et al., 2008; Lewis et al., 2012) are both observed in schizophrenia, a mental disorder that is marked by cognitive impairment (Lesh et al., 2011).”
BackgroundSmucny, J., Dienel, S. J., Lewis, D. A., & Carter, C. S. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01089-0 · Cited by 231
Self-citationMattei, D., Ivanov, A., Ferrai, C., Jordan, P., Guneykaya, D., Buonfiglioli, A., Schaafsma, W., Przanowski, P., Deuther-Conrad, W., Brust, P., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.80 · Cited by 222
Glausier, J. R., Fish, K. N., & Lewis, D. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.152 · Cited by 147
Cognitive impairments in psychotic disorders: common mechanisms and measurement
Barch, D. M., & Sheffield, J. M. (2014) · World Psychiatry · doi:10.1002/wps.20145 · Cited by 154
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
Gomes, F. V., Llorente, R., Del Bel, E. A., Viveros, M.-P., López-Gallardo, M., & Guimarães, F. S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.015 · Cited by 147
Johnson, A. W., Jaaro-Peled, H., Shahani, N., Sedlak, T. W., Zoubovsky, S., Burruss, D., Emiliani, F., Sawa, A., & Gallagher, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307925110 · Cited by 96
Duncan, N. W., Wiebking, C., Tiret, B., Marjańska, M., Hayes, D. J., Lyttleton, O., Doyon, J., & Northoff, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060312 · Cited by 95
Perisomatic inhibition and cortical circuit dysfunction in schizophrenia
Lewis, D. A., Fish, K. N., Arion, D., & Gonzalez-Burgos, G. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.05.013 · Cited by 87
Knowles, E. E. M., Weiser, M., David, A. S., Glahn, D. C., Davidson, M., & Reichenberg, A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.01.018 · Cited by 77
McNally, J. M., McCarley, R. W., & Brown, R. E. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-012-0346-z · Cited by 47
McGrath, L. M., Braaten, E. B., Doty, N. D., Willoughby, B. L., Wilson, H. K., O'Donnell, E. H., Colvin, M. K., Ditmars, H. L., Blais, J. E., Hill, E. N., et al. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12463 · Cited by 43
“Our CFA modeled core domains of EFs from previously established theoretical (Lesh, Niendam, Minzenberg, & Carter, 2011; RDoC Cognitive Group, 2011) and latent variable models (Miyake & Friedman, 2012).”
Clinical correlates of parametric digit-symbol substitution test in schizophrenia
Amaresha, A. C., Danivas, V., Shivakumar, V., Agarwal, S. M., Kalmady, S. V., Narayanaswamy, J. C., & Venkatasubramanian, G. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2014.03.010 · Cited by 43
Fryer, S. L., Roach, B. J., Ford, J. M., Donaldson, K. R., Calhoun, V. D., Pearlson, G. D., Kiehl, K. A., Srihari, V. H., McGlashan, T. H., Woods, S. W., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx198 · Cited by 40
Petrolini, V., Jorba, M., & Vicente, A. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.572035 · Cited by 33
Neural and neuronal discoordination in schizophrenia: from ensembles through networks to symptoms
Krajcovic, B., Fajnerova, I., Horacek, J., Kelemen, E., Kubik, S., Svoboda, J., & Stuchlik, A. (2019) · Acta Physiologica · doi:10.1111/apha.13282 · Cited by 29
Nasiriavanaki, Z., Barbour, T., Farabaugh, A. H., Fava, M., Holmes, A. J., Tootell, R. B. H., & Holt, D. J. (2021) · NeuroImage: Clinical · doi:10.1016/j.nicl.2021.102585 · Cited by 24
Association of histone modification with the development of schizophrenia
Chen, Y.-Z., Zhu, X.-M., Lv, P., Hou, X.-K., Pan, Y., Li, A., Du, Z., Xuan, J.-F., Guo, X., Xing, J.-X., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116747 · Cited by 18
Standke, I., Trempler, I., Dannlowski, U., Schubotz, R. I., & Lencer, R. (2021) · NeuroImage: Clinical · doi:10.1016/j.nicl.2021.102855 · Cited by 11
“Cognitive deficits are considered a core feature of schizophrenia spectrum disorders, and many of them are associated with impaired behavioral and cognitive control (Boudewyn et al. 2012; Lesh et al. 2011; Ragland et al. 2009; Cohen et al. 1999; Barch and Ceaser 2012).”
BackgroundHaddon, J. E., Titherage, D., Heckenast, J. R., Carter, J., Owen, M. J., Hall, J., Wilkinson, L. S., & Jones, M. W. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02969-x · Cited by 6
Metadata
- Authors
- Lesh, T. A., Niendam, T. A., Minzenberg, M. J., & Carter, C. S.
- Venue
- Neuropsychopharmacology
- Published
- 2010-09-15
- Volume
- 36
- Issue
- 1
- Pages
- 316-338
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2074397383
- Cited by
- 506
- References
- 356
- FWCI
- 15.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.